Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pfleiderer

Showing results (561-570 of 612) with videos related to

Pageof 62
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 7, 2010
Synthesis and in vitro evaluation of 2-amino-4-N-piperazinyl-6-(3,4-dimethoxyphenyl)-pteridines as dual immunosuppressive and anti-inflammatory agentsSteven De Jonghe, Arnaud Marchand, Ling-Jie Gao, et al.
Psychotherapy and Psychosomatics|June 28, 2014
Neural correlates of procedural variants in cognitive-behavioral therapy: a randomized, controlled multicenter FMRI studyBenjamin Straube, Ulrike Lueken, Andreas Jansen, et al.
Frontiers in Psychiatry|June 27, 2017
Support Vector Machine Analysis of Functional Magnetic Resonance Imaging of Interoception Does Not Reliably Predict Individual Outcomes of Cognitive Behavioral Therapy in Panic Disorder with AgoraphobiaBenedikt Sundermann, Jens Bode, Ulrike Lueken, et al.
Journal of Affective Disorders|June 22, 2015
Separating depressive comorbidity from panic disorder: A combined functional magnetic resonance imaging and machine learning approachUlrike Lueken, Benjamin Straube, Yunbo Yang, et al.
Kidney International|March 3, 2019
Increased soluble fms-like tyrosine kinase 1 after ischemia reperfusion contributes to adverse clinical outcomes following kidney transplantationTheresa M Wewers, Anna B Mayer, Alexander Pfleiderer, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1981
Core (2'-5')oligoadenylate and the cordycepin analog: inhibitors of Epstein--Barr virus-induced transformation of human lymphocytes in the absence of interferonP W Doetsch, R J Suhadolnik, Y Sawada, et al.
Vaccine|April 20, 2013
A global regulatory science agenda for vaccinesLindsay Elmgren, Xuguang Li, Carolyn Wilson, et al.
Psychological Medicine|April 25, 2013
Altered top-down and bottom-up processing of fear conditioning in panic disorder with agoraphobiaU Lueken, B Straube, I Reinhardt, et al.
Journal of Clinical Medicine|October 16, 2024
A Prospective, Randomized Trial of Bioresorbable Polymer Drug-Eluting Stents versus Fully Bioresorbable Scaffolds in Patients Undergoing Coronary StentingJens Wiebe, Robert A Byrne, Christian Bradaric, et al.
Science Advances|October 5, 2017
Entropy-limited topological protection of skyrmionsJohannes Wild, Thomas N G Meier, Simon Pöllath, et al.
Pageof 62

Showing results (561-570 of 612) with videos related to

Sort By:
Pageof 62
Bioorganic & Medicinal Chemistry Letters|December 7, 2010
Synthesis and in vitro evaluation of 2-amino-4-N-piperazinyl-6-(3,4-dimethoxyphenyl)-pteridines as dual immunosuppressive and anti-inflammatory agentsSteven De Jonghe, Arnaud Marchand, Ling-Jie Gao, et al.
Psychotherapy and Psychosomatics|June 28, 2014
Neural correlates of procedural variants in cognitive-behavioral therapy: a randomized, controlled multicenter FMRI studyBenjamin Straube, Ulrike Lueken, Andreas Jansen, et al.
Frontiers in Psychiatry|June 27, 2017
Support Vector Machine Analysis of Functional Magnetic Resonance Imaging of Interoception Does Not Reliably Predict Individual Outcomes of Cognitive Behavioral Therapy in Panic Disorder with AgoraphobiaBenedikt Sundermann, Jens Bode, Ulrike Lueken, et al.
Journal of Affective Disorders|June 22, 2015
Separating depressive comorbidity from panic disorder: A combined functional magnetic resonance imaging and machine learning approachUlrike Lueken, Benjamin Straube, Yunbo Yang, et al.
Kidney International|March 3, 2019
Increased soluble fms-like tyrosine kinase 1 after ischemia reperfusion contributes to adverse clinical outcomes following kidney transplantationTheresa M Wewers, Anna B Mayer, Alexander Pfleiderer, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1981
Core (2'-5')oligoadenylate and the cordycepin analog: inhibitors of Epstein--Barr virus-induced transformation of human lymphocytes in the absence of interferonP W Doetsch, R J Suhadolnik, Y Sawada, et al.
Vaccine|April 20, 2013
A global regulatory science agenda for vaccinesLindsay Elmgren, Xuguang Li, Carolyn Wilson, et al.
Psychological Medicine|April 25, 2013
Altered top-down and bottom-up processing of fear conditioning in panic disorder with agoraphobiaU Lueken, B Straube, I Reinhardt, et al.
Journal of Clinical Medicine|October 16, 2024
A Prospective, Randomized Trial of Bioresorbable Polymer Drug-Eluting Stents versus Fully Bioresorbable Scaffolds in Patients Undergoing Coronary StentingJens Wiebe, Robert A Byrne, Christian Bradaric, et al.
Science Advances|October 5, 2017
Entropy-limited topological protection of skyrmionsJohannes Wild, Thomas N G Meier, Simon Pöllath, et al.
Pageof 62